Long-Term Persistence of Hormonal Adaptations to Weight Loss
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Background After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss. Methods We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite. Results Weight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P Conclusions One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hormonal and metabolic changes induced by weight reduction result in elevated appetite and reduced metabolic rate [13][14][15].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [13]
In the citing paper
“Weight loss is accompanied by persistent endocrine adaptations30 that increase appetite and decrease satiety31 thereby resisting continued weight loss and conspiring against long-term weight maintenance.”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [30]
In the citing paper
“studies have shown that the pandemic was associated with weight gain in the general population. 25”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [25]
In the citing paper
“and to increased appetite. 9-11”
From Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (2021) · cites this paper as [10]
In the citing paper
“although only 2% of eligible patients are currently receiving therapy [17].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [17]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012
Cited by
Items 301–400 of 1,004
Compensation in response to energy deficits induced by exercise or diet
Doucet, É., McInis, K., & Mahmoodianfard, S. (2018) · Obesity Reviews · doi:10.1111/obr.12783 · Cited by 58
“(22) reported that peripheral hormonal signals (ghrelin, leptin, PYY, CCK, GIP, PP) known to influence feeding mirrored the weight loss-induced increase in appetite as far as 1 year after the intervention.”
BackgroundHoddy, K. K., Gibbons, C., Kroeger, C. M., Trepanowski, J. F., Barnosky, A., Bhutani, S., Gabel, K., Finlayson, G., & Varady, K. A. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.011 · Cited by 60
Randomized double‐blind placebo‐controlled study of leptin administration after gastric bypass
Korner, J., Conroy, R., Febres, G., J. McMahon, D., Conwell, I., Karmally, W., & Aronne, L. J. (2013) · Obesity · doi:10.1002/oby.20433 · Cited by 60
Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial
Weiss, C. R., Akinwande, O., Paudel, K., Cheskin, L. J., Holly, B. P., Hong, K. K., Fischman, A. M., Patel, R. S., Shin, E. J., Steele, K. E., et al. (2017) · Radiology · doi:10.1148/radiol.2016160914 · Cited by 60
Lim, Y. Z., Wong, J. O., Hussain, S. M., Estee, M. M., Zolio, L., Page, M. J., Harrison, C. L., Wluka, A. E., Wang, Y., & Cicuttini, F. (2022) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2022.100298 · Cited by 63
Müllertz, A. L. O., Sandsdal, R. M., Jensen, S. B. K., & Torekov, S. S. (2024) · Obesity Reviews · doi:10.1111/obr.13717 · Cited by 46
“18,19 Weight loss decreases energy expenditure, increases sedentary behavior, and may affect appetite 20,21 with observations of increased appetite at least a year after diet-induced weight loss in some studies, 22 – 24 which makes sustained weight loss difficult.”
BackgroundGilden, A. H., Catenacci, V. A., & Taormina, J. M. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202405210 · Cited by 60
Tirzepatide for overweight and obesity management
Hamza, M., Papamargaritis, D., & Davies, M. J. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2436595 · Cited by 43
“However, even with the most intensive lifestyle interventions, the mean WL typically does not exceed 10% and long-term weight maintenance remains challenging due to physiological compensatory mechanisms (such as increased appetite and reduced energy expenditure) that promote weight regain [6–8].”
Deighton, K., Batterham, R. L., & Stensel, D. J. (2014) · Appetite · doi:10.1016/j.appet.2014.06.003 · Cited by 74
“In this regard, research has demonstrated that compensatory changes in gastrointestinal hormones and increases in appetite persist for at least 1 year after weight loss induced by a very low energy diet, despite increases in body weight (Sumithran et al., 2011).”
BackgroundStrategies to Prevent Weight Gain in Adults
Hutfless, S. M., Gudzune, K. A., Maruthur, N. M., Wilson, R. F., Bleich, S. N., Lau, B. D., Fawole, O. A., Anderson, C. A. M., & Segal, J. B. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.07.013 · Cited by 61
“Preventing weight gain may be easier than achieving weight loss because metabolic hormone changes or altered body weight set-points among those who are overweight and obese may make maintenance of weight loss difficult.(3,4) Individuals who maintain weight after weight loss frequently have to consume fewer calories an…”
BackgroundMann, T. L., Tomiyama, A. J., & Ward, A. C. (2015) · Perspectives on Psychological Science · doi:10.1177/1745691615586401 · Cited by 64
“…M anuscript A uthor M anuscript A uthor M anuscript Simultaneously, hormonal changes increase feelings of hunger and reduce one’s sense of fullness (Sumithran et al., 2011), and metabolic changes allow the body to sustain itself on fewer calories, resulting in greater fat storage (Leibel,…”
BackgroundMancini, M. C., & de Melo, M. E. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0242-0 · Cited by 54
“They highlight the importance of strategies to counteract this change in order to prevent obesity recidivism, otherwise, the long-term outcomes will remain unsatisfactory [29].”
BackgroundDong, Z., Xu, L., Liu, H., Lv, Y., Zheng, Q., & Li, L. (2017) · Obesity Reviews · doi:10.1111/obr.12606 · Cited by 57
“Studies have suggested that long-term diet and weight loss could influence the secretion of appetite-related circulating mediators in the body and that the changes in these circulating mediators were maintained after 1 year (22).”
BackgroundNew pharmacological approaches for obesity management
Rueda‐Clausen, C. F., Padwal, R. S., & Sharma, A. M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.113 · Cited by 61
Brown adipose tissue in humans: Therapeutic potential to combat obesity
Carey, A. L., & Kingwell, B. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.009 · Cited by 57
Saunders, K. H., Shukla, A. P., Igel, L. I., Kumar, R. B., & Aronne, L. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.005 · Cited by 60
“These changes are associated with alterations in a range of hormones.(4,5) According to the 2013 American Heart Association, American College of Cardiology, and The Obesity Society Guideline for the Management of Overweight and Obesity in Adults, pharmacotherapy for the treatment of obesity can be considered if a pati…”
BackgroundCognitive dysfunction is a risk factor for overeating and obesity.
Gunstad, J., Sanborn, V. E., & Hawkins, M. A. W. (2020) · American Psychologist · doi:10.1037/amp0000585 · Cited by 58
Dicker, D., Alfadda, A. A., Coutinho, W., Cuevas, A., Halford, J. C. G., Hughes, C. A., Iwabu, M., Kang, J.-H., Nawar, R., Reynoso, R., et al. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.01.019 · Cited by 56
Thomas, D. M., Martin, C. K., Redman, L. M., Heymsfield, S. B., Lettieri, S., Levine, J. A., Bouchard, C., & Schoeller, D. A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079822 · Cited by 56
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity
Suplicy, H. L., Boguszewski, C. L., dos Santos, C. M. C., de Figueiredo, M. D. D., da Cunha, D. R., & Radominski, R. B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.225 · Cited by 59
Impact of weight regain on metabolic disease risk: a review of human trials.
Kroeger, C. M., Hoddy, K. K., & Varady, K. A. (2014) · Journal of Obesity · doi:10.1155/2014/614519 · Cited by 55
“More specifically, some studies demonstrate sustained improvements in plasma lipids and glucoregulatory factors with minor weight regain, while others report a complete reversal towards baseline.”
BackgroundSurgical Weight Loss: Impact on Energy Expenditure
Thivel, D., Brakonieki, K., Duche, P., Béatrice, M., Yves, B., & Laferrère, B. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0839-1 · Cited by 52
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
Sumithran, P., & Proietto, J. (2014) · Drug Safety · doi:10.1007/s40264-014-0210-7 · Cited by 63
“Diet-induced weight loss is accompanied by a number of compensatory changes, including reductions in circulating leptin and CCK, an increase in the orexigenic hormone ghrelin, an increase in subjective appetite and reduced energy expenditure, which collectively encourage weight regain [15, 16].”
BackgroundSelf-citationPharmacological Approaches in the Treatment and Maintenance of Weight Loss
Van Gaal, L., & Dirinck, E. (2016) · Diabetes Care · doi:10.2337/dcs15-3016 · Cited by 52
“In the short-term, diet-induced weight loss increases orexigenic hormones ghrelin and gastric inhibitory polypeptide (GIP) and decreases anorexigenic hormones leptin, peptide YY, cholecystokinin, amylin, and glucagonlike peptide 1 (GLP-1) (4,5).”
BackgroundCurrent and future pharmacotherapies for obesity in children and adolescents
Kelly, A. S. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00858-9 · Cited by 54
Physiological and Epigenetic Features of Yoyo Dieting and Weight Control
Contreras, R. E., Schriever, S. C., & Pfluger, P. T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01015 · Cited by 59
“Such altered levels of circulating hormones that facilitate weight regain appear to persist for at least 1 year (Sumithran et al., 2011; Camps et al., 2013).”
BackgroundTirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
Corrao, S., Pollicino, C., Maggio, D., Torres, A., & Argano, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1402583 · Cited by 63
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 58
Sears, B., & Ricordi, C. (2012) · PubMed · Cited by 75
Roman, M., Monaghan, A., Serraino, G. F., Miller, D., Pathak, S., Lai, F., Zaccardi, F., Ghanchi, A., Khunti, K., Davies, M. J., et al. (2019) · Journal of British Surgery · doi:10.1002/bjs.11001 · Cited by 53
Chromatin modifications in metabolic disease: Potential mediators of long‐term disease risk
Costello, K. R., & Schones, D. E. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1416 · Cited by 59
“Similarly, many obese people find it difficult to maintain weight loss (Anderson, Konz, Frederich, & Wood, 2001; Kramer, Jeffery, Forster, & Snell, 1989) due to long-term physiological changes contributing to weight regain (Rosenbaum, Hirsch, Gallagher, & Leibel, 2008; Sumithran et al., 2011).”
BackgroundMuñoz, J. S. G., Jiménez‐Rodríguez, D., & Morante, J. J. H. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0375-7 · Cited by 56
“[30], authors observed that at 10 weeks post-intervention (mean weight loss of 13 kg), plasma GLP-1 levels remained unchanged, and only after 62 weeks (mean weight loss of 62 kg), GLP-1 levels slightly decreased.”
BackgroundKhoo, C. M., Muehlbauer, M. J., Stevens, R. D., Pamuklar, Z. N., Chen, J., Newgard, C. B., & Torquati, A. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e318296633f · Cited by 56
Statins decrease leptin expression in human white adipocytes
Singh, P., Zhang, Y., Sharma, P., Covassin, N., Souček, F., Friedman, P. A., & Somers, V. K. (2018) · Physiological Reports · doi:10.14814/phy2.13566 · Cited by 55
“Furthermore, a disproportionate decrease in leptin during weight loss is linked to increased hunger and weight regain after initial weight loss (Sumithran et al. 2011).”
BackgroundThe challenges of implementing behaviour changes that lead to sustained weight management
Stubbs, R. J., & Lavin, J. (2013) · Nutrition Bulletin · doi:10.1111/nbu.12002 · Cited by 59
The Role of Glucagon-Like Peptide-1 in Energy Homeostasis
Salehi, M., & Purnell, J. Q. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0088 · Cited by 46
Dana, L. M., Chapman, K. L., Dixon, H., Miller, C. L., Neal, B. C., Kelly, B., Ball, K., & Pettigrew, S. (2021) · Food Quality and Preference · doi:10.1016/j.foodqual.2021.104199 · Cited by 54
Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes
Almuwaqqat, Z., Hui, Q., Liu, C., Zhou, J. J., Voight, B. F., Ho, Y.-L. A., Posner, D. C., Vassy, J. L., Gaziano, J. M., Cho, K., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3062 · Cited by 57
Quist, J. S., Rosenkilde, M., Petersen, M. B., Gram, A. S., Sjödin, A. M., & Stallknecht, B. M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.253 · Cited by 57
Rajamoorthi, A., LeDuc, C. A., & Thaker, V. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032491 · Cited by 58
“There are several physiological mechanisms that explain why sustained weight loss through lifestyle modifications remains difficult (7, 17).”
BackgroundInfluentialCarey, A. L., Pajtak, R., Formosa, M. F., van Every, B., Bertovic, D. A., Anderson, M. J., Eikelis, N., Lambert, G. W., Kalff, V., Duffy, S. J., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3543-6 · Cited by 51
Weight Loss Is Not the Answer: A Well‐being Solution to the “Obesity Problem”
Logel, C. R., Stinson, D. A., & Brochu, P. M. (2015) · Social and Personality Psychology Compass · doi:10.1111/spc3.12223 · Cited by 54
“These include shifts in appetite-regulatory hormones that increase subjective appetite (Sumithran et al., 2011) and changes in metabolism that reduce energy expenditure (Brownell, 1991; Leibel, Rosenbaum, & Hirsch, 1995), which can persist up to a year after weight loss occurs.”
BackgroundAGA Technical Review on Intragastric Balloons in the Management of Obesity
Shah, R., Davitkov, P., Dayyeh, B. K. A., Saumoy, M., & Murad, M. H. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.043 · Cited by 52
Current concepts in management of weight regain following bariatric surgery
Shukla, A. P., He, D., Saunders, K. H., Andrew, C., & Aronne, L. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1447922 · Cited by 49
“Weight loss induced by diet and exercise alone is countered by adaptive changes in energy expenditure [2] and an increase in orexigenic hormonal signaling, which opposes the maintenance of a lower body weight and favors weight regain [3].”
BackgroundThom, G., Dombrowski, S. U., Brosnahan, N., Algindan, Y. Y., Rosario Lopez-Gonzalez, M., Roditi, G., Lean, M. E. J., & Malkova, D. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0568-9 · Cited by 49
“Other studies have used appetite rating scales at set timepoints to coincide with blood collection for appetite hormone measurements [11, 18, 50].”
BackgroundResultHuman Biology of Weight Maintenance after Weight Loss
Mariman, E. C. M. (2012) · Lifestyle Genomics · doi:10.1159/000337081 · Cited by 52
Kentish, S. J., O’Donnell, T. A., Frisby, C. L., Li, H., Wittert, G., & Page, A. J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.138 · Cited by 51
Malabsorption as a Therapeutic Approach in Bariatric Surgery
Billeter, A. T., Fischer, L., Wekerle, A.-L., Senft, J. D., & Müller-Stich, B. P. (2014) · Visceral Medicine · doi:10.1159/000363480 · Cited by 60
Viewpoint article: Childhood obesity – looking back over 50 years to begin to look forward
Sabin, M. A., Kao, K., Juonala, M., Baur, L. A., & Wake, M. A. (2015) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12819 · Cited by 56
Physiology of Energy Expenditure in the Weight‐Reduced State
Ravussin, E., Smith, S. R., & Ferrante, A. W. (2021) · Obesity · doi:10.1002/oby.23095 · Cited by 48
The regulation of gastric ghrelin secretion
Nunez‐Salces, M., Li, H., Feinle‐Bisset, C., Young, R. L., & Page, A. J. (2020) · Acta Physiologica · doi:10.1111/apha.13588 · Cited by 49
Coutinho, S. R., Rehfeld, J. F., Holst, J. J., Kulseng, B., & Martins, C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00322.2017 · Cited by 44
The role of macronutrient content in the diet for weight management
Bray, G. A., & Siri-Tarino, P. W. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.009 · Cited by 47
Monnier, L., Schlienger, J.-L., Colette, C., & Bonnet, F. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.09.002 · Cited by 47
Nicklas, B. J., Gaukstern, J. E., Beavers, K. M., Newman, J. C., Leng, X., & Rejeski, W. J. (2014) · Obesity · doi:10.1002/oby.20732 · Cited by 46
“Difficulty in maintaining lost weight is in part due to the “energy gap” caused by adaptive thermogenesis and the drive to defend existing energy stores (7-10).”
BackgroundShantha, G. P. S., Kumar, A. A., Kahan, S., & Cheskin, L. J. (2012) · The Diabetes Educator · doi:10.1177/0145721712443293 · Cited by 45
“Sumithran et al(32) showed that peripherally produced hormonal signals, such as leptin, decrease drastically after successful weight loss and remain significantly suppressed compared with their pre–weight loss levels even after 1 year of weight loss.(32)”
BackgroundMakaronidis, J. M., & Batterham, R. L. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.006 · Cited by 45
The relationship between intuitive eating and body image is moderated by measured body mass index
Keirns, N. G., & Hawkins, M. A. W. (2019) · Eating Behaviors · doi:10.1016/j.eatbeh.2019.04.004 · Cited by 47
“This effect could indicate that though eating for physical need is generally helpful, it becomes more difficult at higher BMIs due to the decreased satiety and heightened hunger signaling commonly observed in obesity [23, 24].”
BackgroundOld Paradoxes and New Opportunities for Appetite Control in Obesity
Montégut, L., López-Otín, C., Magnan, C., & Kroemer, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.005 · Cited by 48
Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass
de Hollanda, A., Jiménez, A., Corcelles, R., Lacy, A. M., Patrascioiu, I., & Vidal, J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.022 · Cited by 52
“Compensatory mechanisms involving gastrointestinal hormones participating in energy balance have been proposed to limit sustained weight loss after dietary interventions [25].”
BackgroundSatiety Associated with Calorie Restriction and Time-Restricted Feeding: Peripheral Hormones
Tacad, D. K. M., Tovar, A. P., Richardson, C. E., Horn, W. F., Krishnan, G. P., Keim, N. L., & Krishnan, S. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac014 · Cited by 41
“remained elevated at the 62wk weight maintenance follow-up period (58).”
InfluentialAlpha-Melanocyte-Stimulating Hormone-Mediated Appetite Regulation in the Central Nervous System
Wu, Q., Chen, J., Hua, T., & Cai, J. (2023) · Neuroendocrinology · doi:10.1159/000530804 · Cited by 51
Pekkarinen, T., Kaukua, J., & Mustajoki, P. (2015) · Journal of Obesity · doi:10.1155/2015/651460 · Cited by 43
Farey, J. E., Preda, T. C., Fisher, O. M., Levert‐Mignon, A., Stewart, R. L., Karsten, E., Herbert, B. R., Swarbrick, M. M., & Lord, R. V. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2302-1 · Cited by 50
Non‐pharmacological interventions in non‐alcoholic fatty liver disease patients
Ratziu, V. (2017) · Liver International · doi:10.1111/liv.13311 · Cited by 48
The influence of skeletal muscle on appetite regulation
Grannell, A., VITO, G. D., Murphy, J. C., & le Roux, C. W. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1618185 · Cited by 47
“reported which may explain the increase in subjective feels of hunger [133,134,138,139].”
BackgroundKhoury, T., & Ilan, Y. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.02.003 · Cited by 46
Ahmed, I. A. B. (2024) · Journal of Obesity · doi:10.1155/2024/8056440 · Cited by 53
“It has been posited that one potential mechanism underlying the phenomenon of weight regain or plateauing could be attributed to a decrease in leptin concentrations following initial weight reduction [38, 41].”
InfluentialPharmacotherapy for the treatment of obesity
Sweeting, A., HOCKING, S. L., & Markovic, T. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.005 · Cited by 55
Donaghue, N., & Allen, M. (2015) · International Journal of Sport and Exercise Psychology · doi:10.1080/1612197x.2015.1016086 · Cited by 51
“…prescriptions to “eat less and move more” are becoming complicated by research findings that show how a wide range of metabolic processes are affected by weight loss and implicated in the weight regain that often follows (e.g. Rosenbaum, Hirsch, Gallagher, & Leibel, 2008; Sumithran et al., 2011).”
BackgroundDankel, S. N., Degerud, E. M., Borkowski, K., Fjære, E., Midtbø, L. K., Haugen, C., Solsvik, M. H., Lavigne, A. M., Liaset, B., Sagen, J. V., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00188.2013 · Cited by 44
Gilardini, L., Pasqualinotto, L., Pierro, F. D., RISSO, P., & Invitti, C. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1214-x · Cited by 45
“pathways mediating the utilization and storage of energy and the regulation of appetite [1].”
BackgroundBuckland, N. J., Camidge, D., Croden, F., Lavin, J., Stubbs, R. J., Hetherington, M. M., Blundell, J. E., & Finlayson, G. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy041 · Cited by 49
“Adherence to an LED diet may help limit the effect of physiologic changes that weaken satiety and promote weight regain subsequent to weight loss (42).”
BackgroundNeuroendocrine adaptations to bariatric surgery
Dixon, J. B., Lambert, É., & Lambert, G. W. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.033 · Cited by 49
“Behavioral weight loss produces powerful physiological responses to reverse the process, providing the perfect storm for weight (fat) regain (Rosenbaum et al., 2008a, 2010; Sumithran et al., 2011).”
Dhurandhar, N. V. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01088-1 · Cited by 54
“For example, mechanisms exist in an individual to resist excessive weight gain or weight loss [2, 10].”
BackgroundAzuri, J., Hammerman, A., Aboalhasan, E., Sluckis, B., & Arbel, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14940 · Cited by 40
“mainstay of management is lifestyle modification, but long-term outcomes for sustained weight loss are poor.(1,2,8,9) Novel pharmacological treatments have recently been approved as adjunct therapies for weight reduction.”
BackgroundWharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 54
Weight Loss after Left Gastric Artery Embolization: A Systematic Review and Meta-Analysis
Hafezi‐Nejad, N., Bailey, C. R., Gunn, A. J., & Weiss, C. R. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.06.020 · Cited by 46
Obesity-induced changes in lipid mediators persist after weight loss
Hernandez, A. M., Weber, N., Frano, M. R. L., Ying, W., Lantero‐Rodriguez, J., Sears, D. D., Wallenius, V., Börgeson, E., Newman, J. W. I., & Osborn, O. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.266 · Cited by 45
Peters, A., & McEwen, B. S. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.019 · Cited by 50
Madsbad, S., & Holst, J. J. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2472408 · Cited by 43
“Lifestyle intervention may induce weight losses of about 5–10 kg, but most people will regain weight after 6–12 months follow-up, resulting in only small and unsatisfactory weight losses [4,5].”
Kessler, C. (2021) · Nursing Clinics of North America · doi:10.1016/j.cnur.2021.08.001 · Cited by 43
Theodorakis, N., Kreouzi, M., Pappas, A., & Nikolaou, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413438 · Cited by 43
Brown, A., & Leeds, A. R. (2019) · Nutrition Bulletin · doi:10.1111/nbu.12372 · Cited by 43
“…in subjective hunger has been reported and associated with higher circulating levels of ghrelin (a hunger hormone) and lower circulating levels of peptide YY (PYY), leptin, amylin and cholecystokinin (satiety hormones) compared to baseline (Sumithran et al. 2011, 2013; Purcell et al. 2014).”
ResultRyan, D. H., Barquera, S., Cavalcanti, O. B., & Ralston, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-45009-0_39 · Cited by 64
Peripheral neural targets in obesity
Page, A. J., Symonds, E., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01951.x · Cited by 43
“Very recent evidence suggests that increased drive to eat upon dieting is a result of decreased gut hormone release, rather than being entirely a psychological phenomenon (Sumithran et al., 2011).”
BackgroundObesity and Coronary Artery Disease: Evaluation and Treatment
Garcia‐Labbé, D., Ruka, E., Bertrand, O. F., Voisine, P., Costerousse, O., & Poirier, P. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.008 · Cited by 50
Plasma Ghrelin Levels and Weight Regain After Roux-en-Y Gastric Bypass Surgery
Dayyeh, B. K. A., Jirapinyo, P., & Thompson, C. C. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2418-3 · Cited by 47
Weight Loss and Appetite Control in Women
Hintze, L. J., Mahmoodianfard, S., Auguste, C. B., & Doucet, É. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0273-8 · Cited by 48
Otten, J., Ryberg, M., Mellberg, C., Andersson, T., Chorell, E., Lindahl, B., Larsson, C., Holst, J. J., & Olsson, T. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0082 · Cited by 36
DeBenedictis, J. N., Nymo, S., Ollestad, K. H., Boyesen, G. A., Rehfeld, J. F., Holst, J. J., Truby, H., Kulseng, B., & Martins, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa202 · Cited by 40
“For example, WL has been shown to lead to increased secretion of the hunger hormone ghrelin and a reduction in the postprandial secretion of satiety peptides, such as active glucagon-like peptide 1 (GLP-1), total peptide YY (PYY), and cholecystokinin (CCK) (6, 7).”
BackgroundResultInfluentialAl-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 46
Inhibitory control as a potential treatment target for obesity
de Klerk, M. T., Smeets, P. A. M., & la Fleur, S. E. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2053406 · Cited by 47
“The DLPFC is localized over 3 frontal gyri: the inferior frontal gyrus (IFG), the middle frontal gyrus (MFG), and the superior frontal gyrus (SFG) [27].”
BackgroundMethodInfluentialRosenkilde, M., Reichkendler, M. H., Auerbach, P., Toräng, S., Gram, A. S., Ploug, T., Holst, J. J., Sjödin, A. M., & Stallknecht, B. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00680.2013 · Cited by 51
“The potential homeostatic mechanisms that oppose a negative energy balance induced by chronic caloric restriction are increased postprandial concentrations of ghrelin (12, 41) and/or a blunted PYY3–36 response (34) associated with increased motivation to eat (i.”
BackgroundJensen, S. B. K., Janus, C., Lundgren, J. R., Juhl, C. R., Sandsdal, R. M., Olsen, L. M., Andresen, A., Borg, S. A., Jacobsen, I. C., Finlayson, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32307-y · Cited by 42
The impact of acute exercise on appetite control: Current insights and future perspectives
Thackray, A. E., & Stensel, D. J. (2023) · Appetite · doi:10.1016/j.appet.2023.106557 · Cited by 46
New insights in the mechanisms of weight‐loss maintenance: Summary from a Pennington symposium
Flanagan, E. W., Spann, R., Berry, S. E., Berthoud, H., Broyles, S., Foster, G. D., Krakoff, J., Loos, R. J. F., Lowe, M. R., Ostendorf, D. M., et al. (2023) · Obesity · doi:10.1002/oby.23905 · Cited by 40
“Importantly, leptin levels are observed to be significantly below baseline 1 year following weight loss [29].”
BackgroundPharmacological management of obesity an endocrine society clinical practice guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.23.59-63 · Cited by 41
Rosenbaum, M., Goldsmith, R. L., Haddad, F., Baldwin, K. M., Smiley, R., Gallagher, D., & Leibel, R. L. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2018 · Cited by 42
Weight Management in Obstructive Sleep Apnea
Tham, K. W., Lee, P. C., & Lim, C. H. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.10.002 · Cited by 47
Metadata
- Authors
- Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J.
- Affiliations
- The University of Melbourne (AU)
- La Trobe University (AU)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-27
- Volume
- 365
- Issue
- 17
- Pages
- 1597-1604
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167222546
- Semantic Scholar
- 3a76a35458f699a743f3d47b276f2fea2ca1d1c0
- Cited by
- 1,449
- References
- 39
- Citations by year
- 2026: 128 · 2025: 98 · 2024: 97 · 2023: 99 · 2022: 104 · 2021: 109 · 2020: 104 · 2019: 92 · 2018: 101 · 2017: 101 · 2016: 86 · 2015: 79 · 2014: 78 · 2013: 95 · 2012: 75
- FWCI
- 37.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- weight loss, hormonal adaptation, appetite, leptin, ghrelin, peptide YY, cholecystokinin, glucose-dependent insulinotropic polypeptide, pancreatic polypeptide, amylin, glucagon-like peptide-1, insulin, very low calorie diet, weight regain
- MeSH terms
- Body Weight, Cholecystokinin, Diet, Reducing, Female, Gastrointestinal Hormones, Humans, Male, Middle Aged, Obesity, Peptides, Weight Loss, Body Mass Index, Postmenopause, Peptide YY, Leptin, Glucagon-Like Peptide 1, Ghrelin, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.